| Date | Time | Source | Headline | Symbol | Company |
| 11/23/2011 | 4:10PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/23/2011 | 2:01PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/23/2011 | 1:39AM | Dow Jones News | Roche Buys Shares In Tender Offer For Anadys Pharmaceuticals | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/16/2011 | 6:02AM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/15/2011 | 5:10PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/14/2011 | 4:55PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/09/2011 | 6:05AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/09/2011 | 6:05AM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/08/2011 | 8:16AM | Marketwired | Acquisition Spotlight Shines on Hepatitis C Drug Developers | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/07/2011 | 5:01PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/07/2011 | 4:05PM | PR Newswire (US) | Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 11/04/2011 | 4:34PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/31/2011 | 9:30AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/26/2011 | 8:16AM | Marketwired | Positive Test Results and Acquisitions Drive Shares of Exelixis and Anadys Higher | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/26/2011 | 6:02AM | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/25/2011 | 5:08PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/25/2011 | 4:25PM | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/25/2011 | 9:34AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/24/2011 | 4:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/21/2011 | 10:53AM | Business Wire | The Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/20/2011 | 3:39PM | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/20/2011 | 9:30AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/20/2011 | 6:08AM | Dow Jones News | Roche MS Drug's Good Test Results Boost Pipeline's Prospects | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/19/2011 | 7:00PM | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/19/2011 | 5:14PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/19/2011 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/19/2011 | 1:12PM | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/18/2011 | 11:30PM | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/18/2011 | 9:00AM | Marketwired | Analyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LP | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 10/17/2011 | 8:32PM | Business Wire | Robbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |